Details

---

Manufacturer

Novugen Pharma Sdn. Bhd.,

Registration number

MAL22106020AZ

Content

30 mg gliclazide

Indication:

Management of type 2 diabetes mellitus in adults who don’t achieve adequate glycemic control with diet, exercise, and weight loss alone

Instruction:

Take one tablet daily, swallowed whole before the first meal; do not chew, crush, or break the tablet